Israeli Finalists Vie for $1 Million at Start Up World Cup » matricelf-ceo-768×432
Asaf Toker, CEO of Matricelf, which is developing a regenerative medicine cure for spinal cord injury. (Metricelf)
Asaf Toker, CEO of Matricelf, which is developing a regenerative medicine cure for spinal cord injury. (Metricelf)